Published in AIDS Weekly, June 28th, 2004
According to a study published in the American Journal on Addictions, "Understanding drug interactions between antiretrovirals and opiate therapies may decrease toxicities and enhance adherence, with improved HIV outcomes in injection drug users."
"We report results of a clinical pharmacology study designed to examine the interaction of the protease inhibitor, nelfinavir, with methadone and LAAM (N=48). Nelfinavir decreased methadone exposure," reported E.F. McCance-Katz, "but no withdrawal was observed over the five day study period."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.